Moreover, HER2-overexpressing breast cancer is known to be more aggressive and resistant to medicinal treatment7, 8, suggesting that improving the method of tumour destruction rather than persistently changing the anticancer drugs used may be required to truly cure this type of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.